Related Experiment Video
Updated: Aug 30, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.7K
[Lipid lowering: new agents and new concepts].
Julia Brandts1, Marlo Verket1, Dirk Müller-Wieland2
1Medizinische Klinik I, Universitätsklinikum RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland.
Herz
|August 26, 2022
Summary
Lowering low-density lipoprotein cholesterol (LDL-C) is crucial for cardiovascular health. New therapies targeting LDL-C offer improved prevention of dyslipidemia and related complications.
Area of Science:
- Cardiovascular Medicine
- Pharmacotherapy
- Lipid Metabolism
Background:
- Low-density lipoprotein cholesterol (LDL-C) is a primary causal risk factor for cardiovascular diseases.
- Current treatment goals for LDL-C are based on risk stratification, guidelines, and individual patient needs.
- Advanced therapeutic strategies now enable LDL-C reduction to levels associated with atherosclerotic plaque regression.
Purpose of the Study:
- To review the evolution of lipid-lowering pharmacotherapy.
- To discuss novel strategies for reducing atherogenic lipoproteins.
- To highlight the impact of LDL-C lowering on cardiovascular disease prevention.
Main Methods:
- Review of current and emerging pharmacotherapies for dyslipidemia.
- Discussion of targeted approaches like PCSK-9, ANGPLT3, ApoC-III, and Apo(a) inhibition.
- Exploration of future therapeutic avenues including vaccination and gene therapy (CRISPR).
Main Results:
- Pharmacotherapy has advanced from enzyme inhibition (statins) to targeted protein neutralization (antibodies).
- Emerging therapies offer specific reduction of atherogenic lipoproteins by targeting mRNA or proteins.
- High patient adherence and effective LDL-C lowering are key to optimizing cardiovascular prevention.
Conclusions:
- Novel therapeutic strategies, potentially with higher adherence, can optimize cardiovascular prevention.
- Early and sustained LDL-C reduction is vital for minimizing cardiovascular complications.
- Future treatments may involve innovative approaches like gene therapy for long-term dyslipidemia management.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
840
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
840
01:26Atherosclerosis III: Management
26
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
26
01:24Lipid Absorption
622
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
622
01:24Overview of Lipid Metabolism
2.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.2K
01:06Lipid Digestion
93.4K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
93.4K
01:31Lipid-derived Compounds in the Human Body
4.7K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.7K